Recently numerous prototype DNA-based biopharmecuticals can be used to control disease progression by induction and inhibitin the overexpression of Genes. Since there are poor cellular uptake and rapid in vivo the overexpression of DNA-based therapeutics therefore the use of delivery systems to facilitate cellular internalization and preserve their activity is necessary. Cationic polymers dommo…